已收盤 07-31 16:00:00 美东时间
-1.550
-2.16%
华盛资讯7月29日讯,BXP Inc公布2026财年Q2业绩,公司Q2营收7.96亿美元,同比增长4.9%,归母净利润0.69亿美元,同比下滑47.3%。
07-29 05:13
BXP (NYSE:BXP) raises FY2026 FFO guidance from $6.90-$7.04 to $6.99-$7.05 vs $6.96 analyst estimate..
07-29 04:09
BXP (NYSE:BXP) is looking for Q3 FFO of $1.80-$1.82 vs $1.81 analyst estimate..
07-29 04:09
Boston Props (NYSE:BXP) reported quarterly earnings of $1.78 per share which beat the analyst consensus estimate of $1.70 by 4.71 percent. This is a 4.09 percent increase over earnings of $1.71 per share from the same period last year. The company reported quarterly sales of $895.699 million which b...
07-29 04:09
今日重点评级关注:HC Wainwright & Co.:维持Greenwich LifeSciences"买入"评级,目标价从50美元升至69美元;高盛:维持Taysha Gene Therapies"买入"评级,目标价从11美元升至13美元
07-22 11:35
Barclays analyst Brendan Lynch maintains BXP (NYSE:BXP) with a Overweight and raises the price target from $65 to $79.
07-21 20:51
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从66.5美元升至72美元;HC Wainwright & Co.:维持Vera Therapeutics"买入"评级,目标价从110美元升至125美元
07-09 12:35
今日重点评级关注:Roth Capital:维持Nuvectis Pharma"买入"评级,目标价从20美元升至33美元;摩根士丹利:维持GXO Logistics"超配"评级,目标价从75美元升至78美元
07-07 11:34
Evercore ISI Group analyst Steve Sakwa maintains BXP (NYSE:BXP) with a In-Line and raises the price target from $67 to $68.
07-06 23:51